Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T-VEC with Isolated Limb Perfusion in Advanced Extremity Tumors
NCT03555032Phase 2Completed
- Sponsor
- Royal Marsden NHS Foundation Trust
- Start
- Jun 2018
- Primary completion
- Aug 2021
- Modality
- Oncolytic Viruses
- Countries
- 1
01
Overview
A Phase 2 trial of talimogene laherparepvec in melanoma, soft tissue sarcoma (STS), sponsored by Royal Marsden NHS Foundation Trust. Started Jun 2018; status: completed.
02
Drugs
talimogene laherparepvec
03
Conditions
melanomasoft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT03555032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03555032.